Live from the NIH registry
Studies recruiting near Colorado Springs right now
Top 25 of 206 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 80 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Boehringer Ingelheim
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
MCB Clinical Research Centers LLC — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
N/A
Interventional 300 participants sought
Colorado ENT & Allergy — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Airiver Medical, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: SWOG Cancer Research Network
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Children's Hospital of Colorado — Colorado Springs, Colorado (4.0 mi)
· Sponsor: St. Jude Children's Research Hospital
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
MCB Clinical Research Centers — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Kallyope Inc.
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Rocky Mountain Cancer Centers-Penrose — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 143 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Eli Lilly and Company
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
UC Health Oncology Research — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Hoffmann-La Roche
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
Schizophrenia, Autism-Related Irritability
Phase 3
Interventional 400 participants sought
Local Institution - 0161 — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Medtronic
Improving Care for Rural Patients With Solid Tumors
Lung Cancer, Head and Neck Cancer
N/A
Interventional 320 participants sought
Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: University of Colorado, Denver
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Eli Lilly and Company
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Peanut Allergies
Phase 1
Interventional 48 participants sought
Asthma and Allergy Associates, PC — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Mabylon AG
VTP-1000 in Adults With Celiac Disease
Celiac Disease
EARLY/Phase 1
Interventional 45 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Barinthus Biotherapeutics
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Multiple conditions
Phase 3
Interventional 158 participants sought
UCHealth Memorial Hospital Central — Colorado Springs, Colorado (4.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 530 participants sought
Peak Gastroenterology Associates — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Janssen Research & Development, LLC
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: NRG Oncology
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina Consultants of Southern Colorado — Colorado Springs, Colorado (4.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: National Cancer Institute (NCI)
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Penrose-Saint Francis Healthcare — Colorado Springs, Colorado (4.0 mi)
· Sponsor: SWOG Cancer Research Network